"Sea Shadows"
France tv distribution announces multiple sales for its Ecological thriller “Sea Shadows” and the movie “The Party's Over!” in multiple territories.
The "Sea Shadows" (6x52’) series has been acquired by NDR/Onegate in Germany; Radio Television Portuguese in Portugal; Walter Presents / Global Series Network in Ireland and the United Kingdom and Blue Entertainment in Switzerland.
This success goes beyond the small screen. "Sea Shadows" won the Audience Award at the Montréal Séries Festival 2024 and was also selected for the official competition at the South International Series Festival 2024 in Spain.
In France, the series set audience records, captivating millions of viewers and establishing itself as a true phenomenon. Thanks to its gripping storyline and deeply human characters, "Sea Shadows" has built a loyal and diverse audience, securing its place among the most-watched series of the year. Overall, the series attracted an average of 4.2 million viewers (18.7% audience share) during its broadcast on France 2 and accumulated 7 million video views within one month on france.tv.
On the other hand, France tv distribution got the first international sales of "The Party's Over!", a film by Antony Cordier ("Gaspard at the Wedding"), produced by Cheyenne Federation, starring Laure Calamy ("How to Make a Killing"), Laurent Lafitte ("Sarah Bernhardt"), Ramzy Bedia ("Mikado"), Élodie Bouchez ("Beating Hearts"), Sami Outalbali ("A Tale of Love and Desire") and Noée Abita ("Sink or Swim").
The film is reaching a new milestone in its international journey and has already attracted several distributors across the following territories: Switzerland – Frenetic; Ukraine – Greenlight Film; Portugal – Cinemundo; Israel – Lev Films; Italy – No.Mad Entertainment; Hungary – Cirko Film; Canada – Axia Films; Australia & New Zealand – Potential Films and Benelux – Vertigo (co-producing territory).
This early commercial success confirms the film’s strong impact beyond borders. In France, it has already drawn over 150,000 cinema admissions and continues to benefit from highly positive critical acclaim.